Pheon Therapeutics

BiVictrix Therapeutics Plc

The company develops selective antibody-drug conjugates for the treatment of various cancers, including liquid and solid tumours, for the pharmaceutical and clinical sectors.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Mersana Therapeutics

This company develops antibody-drug conjugates to treat various cancers for healthcare providers and patients within the oncology sector.

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

Pheast Therapeutics

This immuno-oncology company develops macrophage checkpoint inhibitors for healthcare providers and pharmaceutical partners to treat patients with aggressive solid tumours.

Third Arc Bio

This biotechnology company develops multifunctional antibodies to treat solid tumours and inflammatory diseases for the healthcare sector.